Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

No reported Research & Development figures are available to summarize.

Research & Development history

Currency unavailable · from the income statement

No Research & Development data reported for this period type.

Research & Development vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Research & Development for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$171.97M USD+136.8%+73.1%—
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$162.51M USD-21.6%+18.9%—
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$107.93M USD+58.7%+118.3%539.7%
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$101.99M USD+14.6%+8.4%46.8%
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$49.38M USD+11.3%+45.0%—
GHRSGH Research PLCLTM Mar 2026$43.27M USD+26.5%+23.7%—
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$28.47M USD—+131.7%—
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+20.6%+45.0%293.2%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.